These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 880268)

  • 1. Hepatic uptake, intracellular protein binding and biliary excretion of amethopterin.
    Strum WB; Liem HH
    Biochem Pharmacol; 1977 Jul; 26(13):1235-40. PubMed ID: 880268
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibitory effect of bile salts on the enterohepatic circulation of methotrexate in the unanesthetized rat: inhibition of methotrexate intestinal absorption.
    Said HM; Hollander D
    Cancer Chemother Pharmacol; 1986; 16(2):121-4. PubMed ID: 3948296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biliary excretion of some penicillins, quaternary ammonium compounds and tertiary amines, including aspects on mechanisms for their excretion.
    Ryrfeldt A
    Acta Pharmacol Toxicol (Copenh); 1973; 3():1-23. PubMed ID: 4208884
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of chemotherapeutic agents on the uptake and excretion of amethopterin by the isolated perfused rat liver.
    Strum WB; Liem HH; Muller-Eberhard U
    Cancer Res; 1978 Dec; 38(12):4734-6. PubMed ID: 719650
    [No Abstract]   [Full Text] [Related]  

  • 5. Dose-dependent inhibition of transporter-mediated hepatic uptake and biliary excretion of methotrexate by cyclosporine A in an isolated perfused rat liver model.
    Parasrampuria R; Mehvar R
    J Pharm Sci; 2010 Dec; 99(12):5060-9. PubMed ID: 20821379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to Pediococcus cerevisiae to amethopterin as a consequence of changes in enzymatic activity and cell permeability. II. Permeability changes to amethopterin and other folates in the drug-resistant mutant.
    Mandelbaum-Shavit F
    Biochim Biophys Acta; 1976 May; 428(3):674-82. PubMed ID: 6055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic uptake, intracellular accumulation and biliary secretion of 5-methyltetrahydrofolate.
    Strum WB; Liem HH
    Res Commun Chem Pathol Pharmacol; 1980 Dec; 30(3):493-507. PubMed ID: 7255860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic uptake and biliary excretion of d-tubocurarine and trimethyltubocurarine in the rat in vivo and in isolated perfused rat livers.
    Meijer DK; Weitering JG; Vonk RJ
    J Pharmacol Exp Ther; 1976 Jul; 198(1):229-39. PubMed ID: 933009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic uptake and biliary excretion of dibromosulphthalein. Albumin dependence, influence of phenobarbital and nafenopin pretreatment and the role of y and z protein.
    Meijer DK; Vonk RJ; Keulemans K; Weitering JG
    J Pharmacol Exp Ther; 1977 Jul; 202(1):8-21. PubMed ID: 874820
    [No Abstract]   [Full Text] [Related]  

  • 10. Preliminary model for methotrexate pharmacokinetics.
    Bischoff KB; Dedrick RL; Zaharko DS
    J Pharm Sci; 1970 Feb; 59(2):149-54. PubMed ID: 5411336
    [No Abstract]   [Full Text] [Related]  

  • 11. A functional, active transport system for methotrexate in freshly isolated hepatocytes.
    Horne DW; Briggs WT; Wagner C
    Biochem Biophys Res Commun; 1976 Jan; 68(1):70-6. PubMed ID: 1082335
    [No Abstract]   [Full Text] [Related]  

  • 12. A pH-dependent, carrier-mediated transport system for the folate analog, amethopterin, in rat jejunum.
    Strum WB
    J Pharmacol Exp Ther; 1977 Dec; 203(3):640-5. PubMed ID: 21956
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatic uptake and biliary excretion of organic cations--II. The influence of ion pair formation.
    Neef C; Keulemans KT; Meijer DK
    Biochem Pharmacol; 1984 Dec; 33(24):3991-4002. PubMed ID: 6508848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural specificity of mechanisms controlling the hepatic uptake and biliary output of methotrexate in the rat.
    Deutsch JC; Kolhouse JF
    J Pharmacol Exp Ther; 1989 Jul; 250(1):221-6. PubMed ID: 2746499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic intracellular distribution of foreign compounds in relation to their biliary excretion.
    Levine WG; Singer RW
    J Pharmacol Exp Ther; 1972 Nov; 183(2):411-9. PubMed ID: 5083553
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical pharmacokinetics of methotrexate in psoriasis therapy.
    Hendel J
    Dan Med Bull; 1985 Dec; 32(6):329-37. PubMed ID: 3908004
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolism of cysteinyl leukotrienes in non-recirculating rat liver perfusion. Hepatocyte heterogeneity in uptake and biliary excretion.
    Wettstein M; Gerok W; Häussinger D
    Eur J Biochem; 1989 Apr; 181(1):115-24. PubMed ID: 2565811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of unconjugated bile acids on the enterohepatic circulation of methotrexate.
    Said HM; Strum WB; Hollander D
    J Pharmacol Exp Ther; 1984 Dec; 231(3):660-4. PubMed ID: 6502520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary and biliary excretion of the 2,4-diaminoquinazoline antifolate, methasquin, in rats and dogs.
    Rader JI; Hutchison DJ; Sodergren JE; Vidal P; Philips FS
    Cancer Res; 1971 Jul; 31(7):964-9. PubMed ID: 4997848
    [No Abstract]   [Full Text] [Related]  

  • 20. Evidence that interference with binding to hepatic cytosol binders can inhibit bile acid excretion in rats.
    Takikawa H; Sugiyama Y; Fernandez-Checa JC; Kuhlenkamp J; Ookhtens M; Kaplowitz N
    Hepatology; 1996 Jun; 23(6):1642-9. PubMed ID: 8675188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.